John Russel Denton

See Remarks

John Russel Denton (See Remarks) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Caris Life Sciences, Inc. (CAI). Across 1 priced purchase filing, the average 21-session return was +17.1% from execution and +3.7% from disclosure (delay-adjusted; derived). The largest single filing was $101K of CAI (4,184 sh × $24.09, as filed), executed Nov 7 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+17.1%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+3.7%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$101K

shares × price, as filed

Last traded

Nov 7 2025

Filed Nov 10 2025

Median ADV $49.4M across their filed names

Open performance→

Volume by month

Buys $258K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

CAI

Caris Life Sciences, Inc. CAI · 2 buys · 0 sells 2 filings

Recent filings

CAIPURCHASE Caris Life Sciences, Inc. View filing → $101K
4,184 sh × $24.09
Exec Nov 7 2025
Filed Nov 10 2025 · 8:12 AM ET CAIPURCHASE Caris Life Sciences, Inc. View filing → $158K
7,500 sh × $21.00
Exec Jun 20 2025
Filed Jun 23 2025 · 5:30 PM ET